DocuSign Agreement Preparation
LeaderBringing Agreements to Life
Est 2003|Valuation $15.9B|Raised $1.8B
Published May 15, 2026
Press coverage and independent analysis have noted DocuSign’s expansion beyond eSignature into broader IAM capabilities, including workflow builders and AI-based document processing. Technology press has also reported on the vendor’s investment in AI for contract comprehension and document preparation automation.
| Starting Price | Not clearly public for Agreement Preparation (sales engagement typically required); self-serve eSignature plans have published list pricing | Published list pricing available for Acrobat Standard and Acrobat Pro plans | Published per-seat pricing for Starter and Business tiers, plus a document-limited "Launch" plan |
| Suitable For | Enterprises standardizing agreement creation as part of a broader IAM solution; organizations seeking governance plus downstream signing and repository features | PDF-centric organizations already using Adobe tooling; straightforward eSign and PDF workflows | Sales teams producing proposals and lightweight agreement workflows; teams seeking an integrated document editor with clear list pricing |
| Key Strength | Part of a platform that integrates creation, signing, storage, and analytics; documented compliance certifications published by the vendor | Comprehensive PDF tooling and integration within the Adobe ecosystem; predictable list pricing for common plans | Document creation UX oriented to sales use cases; transparent list pricing and lower-cost entry tiers |
| Key Weakness | Pricing opacity for IAM modules; implementation complexity; community feedback on cost and support | Pricing and plan complexity for some enterprise features; some enterprise controls require higher tiers | Not positioned as a deep CLM for complex contract lifecycles; advanced enterprise controls gated to higher tiers |
Vendor-side comparison pages may assert limitations of competitors. These are vendor marketing claims and should be validated through independent reviews and trials.